BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28508686)

  • 1. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3.
    Sugawara M; Kobayashi E; Asano N; Yoshida A; Kawai A
    Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
    Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
    Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Owosho AA; Estilo CL; Huryn JM; Chi P; Antonescu CR
    Head Neck Pathol; 2018 Jun; 12(2):151-159. PubMed ID: 28762137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.
    Prieto-Granada CN; Wiesner T; Messina JL; Jungbluth AA; Chi P; Antonescu CR
    Am J Surg Pathol; 2016 Apr; 40(4):479-89. PubMed ID: 26645727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
    Ziadi A; Saliba I
    Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens.
    Mito JK; Qian X; Doyle LA; Hornick JL; Jo VY
    Am J Clin Pathol; 2017 Aug; 148(2):179-189. PubMed ID: 28898989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-Induced Glandular Malignant Peripheral Nerve Sheath Tumor.
    John I; Bartlett DL; Rao UNM
    Int J Surg Pathol; 2017 Oct; 25(7):635-639. PubMed ID: 28530162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.
    Le Guellec S; Macagno N; Velasco V; Lamant L; Lae M; Filleron T; Malissen N; Cassagnau E; Terrier P; Chevreau C; Ranchere-Vince D; Coindre JM
    Mod Pathol; 2017 Dec; 30(12):1677-1687. PubMed ID: 28752843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors.
    Thangaiah JJ; Westling BE; Roden AC; Giannini C; Tetzlaff M; Cho WC; Folpe AL
    Ann Diagn Pathol; 2022 Aug; 59():151967. PubMed ID: 35567887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of H3K27me3 immunohistochemistry and combination of NF1 and p16 deletions by fluorescence in situ hybridization in the differential diagnosis of malignant peripheral nerve sheath tumor and its histological mimics.
    Sugita S; Aoyama T; Emori M; Kido T; Takenami T; Sakuraba K; Terai K; Sugawara T; Tsujiwaki M; Hasegawa T
    Diagn Pathol; 2021 Aug; 16(1):79. PubMed ID: 34461930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours.
    Asano N; Yoshida A; Ichikawa H; Mori T; Nakamura M; Kawai A; Hiraoka N
    Histopathology; 2017 Feb; 70(3):385-393. PubMed ID: 27580378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.
    Cleven AH; Sannaa GA; Briaire-de Bruijn I; Ingram DR; van de Rijn M; Rubin BP; de Vries MW; Watson KL; Torres KE; Wang WL; van Duinen SG; Hogendoorn PC; Lazar AJ; Bovée JV
    Mod Pathol; 2016 Jun; 29(6):582-90. PubMed ID: 26990975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL; Nielsen GP
    Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart.
    Agaram NP; Wexler LH; Chi P; Antonescu CR
    Genes Chromosomes Cancer; 2023 Mar; 62(3):131-138. PubMed ID: 36414547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
    Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
    PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic malignant peripheral nerve sheath tumour (MPNST) in a 3-year-old girl: A diagnostic challenge.
    Zawawi MSF; Wan Ismail WFN; Mustapar N; Mohamad N; Nasir A; Tuan Sharif SE
    Malays J Pathol; 2022 Apr; 44(1):115-120. PubMed ID: 35484894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
    Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.
    Schaefer IM; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Jan; 29(1):4-13. PubMed ID: 26585554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.